Resources

Press Releases


February 22, 2021

MatriSys Announces Positive Results From a Phase I Study of MSB-0221 for the Topical Treatment of Atopic Dermatitis


February 18, 2021

TransCode Therapeutics Announces Key Appointments


February 17, 2021

Micronoma Raises $3.5 Million in Convertible Note Financing


December 15, 2020

BioAtla Announces Pricing of Initial Public Offering


December 15, 2020

Castle Biosciences Announces Pricing of $232 Million Public Offering of Public Stock


December 9, 2020

Micronoma Establishes Scientific Advisory Board


November 5, 2020

Merck to Acquire VelosBio


October 15, 2020

Genalyte Obtains FDA Emergency Use Authorization for Rapid COVID-19 Antibody Test


October 13, 2020

Genalyte Appoints Ashraf Hanna, M.D., Ph.D., as Chief Executive Officer


October 5, 2020

Arcturus Therapeutics Announces Completion of First Three Dose Escalation Cohorts in Phase 1 Study of ARCT-810, Therapeutic Candidate for Ornithine Transcarbamylase (OTC) Deficiency


September 30, 2020

Micronoma Appoints Magda Marquet Chairman of the Board


September 29, 2020

ProciseDx Completes Distribution Agreements with D.I.D. in Italy and BHR in the United Kingdom


September 28, 2020

HUYA Bioscience International Announces Orphan Drug Designation for HBI-8000 Monotherapy Adult T-cell Leukemia-Lymphoma ATL in Japan


September 18, 2020

Dreamscape Immersive, ASU launch bold partnership to bring cutting-edge virtual reality to learners worldwide


September 9, 2020

ProciseDx Achieves CE Mark for Infliximab and Adalimumab Point of Care Testing


August 13, 2020

Micronoma Launches with $3 Million Seed Funding


August 10, 2020

Ligand to Acquire Pfenex Inc.


July 29, 2020

Arcturus Therapeutics Announces Pricing of $173 Million Public Offering of Common Stock


July 21, 2020

ProciseDx Secures $10.5 Million Series A Financing Round Led by Biosynex, Forms an Independent Point-Of-Care Diagnostic Company


July 21, 2020

Arcturus Therapeutics & Duke-NUS Received Approval to Proceed with Phase 1/2 Clinical Trial for COVID-19 Vaccine Candidate, LUNAR-COV19


July 15, 2020

BioAtla Raises $72.5 Million in Series D Financing


July 8, 2020

VelosBio Raises $137 Million in Series B Financing to Advance Development of ROR1-Directed Therapeutics in Oncology


May 26, 2020

MatriSys Bioscience Inc. is Pleased to Announce that Magda Marquet PhD has been Appointed Chairwoman of MatriSys’ Board of Directors


May 22, 2020

CalciMedica Raises $15 Million in Series C Financing Round Led by Valence Life Sciences


May 21, 2020

CalciMedica Announces that FDA has Strongly Recommended Moving to a Blinded Placebo-Controlled Trial with Auxora™ in Patients with Severe Covid-19 Pneumonia


May 18, 2020

Seraphina Therapeutics – The First Potential Essential Fatty Acid Discovered in 90 Years


May 8, 2020

Arcturus Reports Additional Supportive Preclinical Data for its COVID-19 Vaccine Candidate (LUNAR-COV19)


May 4, 2020

US FDA Allows Trial to Proceed for Alume Biosciences’ Nerve Imaging Candidate


May 1, 2020

Alume Biosciences Completes $5.5M Series A Financing


April 27, 2020

Arcturus Reports Positive Preclinical Data for its COVID-19 Vaccine Candidate


April 27, 2020

Genalyte Announces Availability of its High-Speed COVID-19 Antibody Test


April 13, 2020

Arcturus Therapeutics Announces Allowance of IND & Approval of Clinical Trial Application (CTA) for ARCT-810, a First-in-Class Investigational mRNA Medicine to Treat Ornithine Transcarbamylase Deficiency


March 27, 2020

Arcturus COVID-19 Vaccine to Benefit from Duke-NUS Genetic Correlation System


March 11, 2020

UCSD Team, and Micronoma Founders, Publish Nature Paper Identifying Nucleic Acid-Based, Tumor-Specific Microbial Signatures in the Blood, Suggesting a New Diagnostic Approach


March 4, 2020

Arcturus Therapeutics and Duke-NUS Medical School Partner to Develop a Coronavirus (COVID-19) Vaccine Using STARR™ Technology


Articles


February 22, 2021

Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial


October 11, 2020

San Diego biotechs have plunged into the fight against COVID-19. Here’s what they’re doing


July 9, 2020

Pandemic Perspectives – Interview with Magda Marquet


May 18, 2020

Arcturus Therapeutics and Duke-NUS – LUNAR-COV19


April 17, 2020

Governor Newsom Taps California Business, Labor, Health Care and Community Leaders for New Task Force on Business and Jobs Recovery


October 10, 2018

Scripps Research Creates Board of Overseers


February 13, 2017

La Jolla Institute Board of Directors Elects Biotech Entrepreneur


January 20, 2016

The San Diego Technology Archive – UCSD Libraries


December 17, 2015

Drs. Magda Marquet and Francois Ferré Selected as 2016 Inductees into the CONNECT Entrepreneur Hall of Fame


September 10, 2015

Executive Q&A: Magda Marquet of Althea Technologies and Alma Life Sciences


February 27, 2013

San Diego Source – Magda Marquet